Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
insulin resistance7794 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A42502 | 34358837 | Clin Nutr | Copper deficiency and nonalcoholic fatty liver disease: The chicken or the egg? | 2021 | Details |
| A42503 | 34358825 | Clin Nutr | Effect of supplementation with calcitriol versus cholecalciferol on insulin resistance in patients with nonalcoholic fatty liver disease: Several issues of concern. | 2021 | Details |
| A42537 | 34221921 | J Clin Transl Hepatol | Efficacy of Intragastric Balloons in the Markers of Metabolic Dysfunction-associated Fatty Liver Disease: Results from Meta-analyses. | 2021 | Details |
| A42547 | 34185279 | Front Med | Low-carbohydrate diets lead to greater weight loss and better glucose homeostasis than exercise: a randomized clinical trial. | 2021 | Details |
| A42559 | 34163039 | Nat Rev Endocrinol | Therapeutic opportunities for pancreatic β-cell ER stress in diabetes mellitus. | 2021 | Details |
| A42566 | 34153303 | Metabolism | Irisin in nonalcoholic fatty liver disease: Need for an updated meta-analysis. | 2021 | Details |
| A42574 | 34133256 | Expert Rev Mol Diagn | Dysregulation of lncRNA-H19 in cardiometabolic diseases and the molecular mechanism involved : a systematic review. | 2021 | Details |
| A42577 | 34125228 | J Clin Endocrinol Metab | Endocrine Dysfunction in Patients With Myotonic Dystrophy. | 2021 | Details |
| A42592 | 34082043 | Biochimie | Roles of microRNAs in carbohydrate and lipid metabolism disorders and their therapeutic potential. | 2021 | Details |
| A42611 | 34023388 | J Biol Chem | Inducible hepatic expression of CREBH mitigates diet-induced obesity, insulin resistance, and hepatic steatosis in mice. | 2021 | Details |
| A42614 | 34015974 | Expert Rev Clin Pharmacol | Update on the effects of GLP-1 receptor agonists for the treatment of polycystic ovary syndrome. | 2021 | Details |
| A42617 | 34011630 | Sci Transl Med | ABCB10 exports mitochondrial biliverdin, driving metabolic maladaptation in obesity. | 2021 | Details |
| A42640 | 33930552 | Clin Gastroenterol Hepatol | Weight Change and the Development of Nonalcoholic Fatty Liver Disease in Metabolically Healthy Overweight Individuals. | 2021 | Details |
| A42654 | 33869980 | J Endocr Soc | Removal of Epididymal Visceral Adipose Tissue Prevents Obesity-Induced Multi-organ Insulin Resistance in Male Mice. | 2021 | Details |
| A42665 | 33856174 | Am Fam Physician | NAFLD in Children and Adolescents. | 2021 | Details |
| A42666 | 33849008 | J Innate Immun | Innate Immune Cells in the Adipose Tissue in Health and Metabolic Disease. | 2021 | Details |
| A42677 | 33819416 | J Pediatr Endocrinol Metab | Prevalence of elevated liver enzymes and their association with type 2 diabetes risk factors in children. | 2021 | Details |
| A42680 | 33809508 | Pharmaceuticals (Basel) | Doxepin Exacerbates Renal Damage, Glucose Intolerance, Nonalcoholic Fatty Liver Disease, and Urinary Chromium Loss in Obese Mice. | 2021 | Details |
| A42690 | 33759592 | Angiology | AST to ALT Ratio and Peripheral Arterial Disease in a Hypertensive Population-Is There a Link? | 2021 | Details |
| A42703 | 33717101 | Front Immunol | Natural Killer Cells: Friend or Foe in Metabolic Diseases? | 2021 | Details |
| A42704 | 33712438 | Gut | NAFLD in lean individuals: not a benign disease. | 2021 | Details |
| A42708 | 33682953 | Nutr Clin Pract | Endogenous Glucose Production in Critical Illness. | 2021 | Details |
| A42709 | 33682344 | FEBS J | Metabolic roles of G protein-coupled receptor signaling in obesity and type 2 diabetes. | 2021 | Details |
| A42736 | 33604315 | J Hepatocell Carcinoma | Mechanisms Underlying Hepatocellular Carcinoma Progression in Patients with Type 2 Diabetes. | 2021 | Details |
| A42742 | 33596631 | J Biol Regul Homeost Agents | Vitamin D3 supplementation in controlling metabolic changes associated with non-alcoholic steatohepatitis. | 2021 | Details |
| A42748 | 33586679 | J Clin Invest | Muscle Krüppel-like factor 15 regulates lipid flux and systemic metabolic homeostasis. | 2021 | Details |
| A42749 | 33586126 | Am J Clin Dermatol | Psoriasis in Patients with Metabolic Syndrome or Type 2 Diabetes Mellitus: Treatment Challenges. | 2021 | Details |
| A42755 | 33568795 | Nat Rev Gastroenterol Hepatol | The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer. | 2021 | Details |
| A42758 | 33561215 | J Nutr | Associations of Serum Fatty Acid Proportions with Obesity, Insulin Resistance, Blood Pressure, and Fatty Liver: The Cardiovascular Risk in Young Finns Study. | 2021 | Details |
| A42770 | 33525643 | Nutrients | The Marine Microalga, Tisochrysis lutea, Protects against Metabolic Disorders Associated with Metabolic Syndrome and Obesity. | 2021 | Details |
| A42776 | 33508742 | Redox Biol | Long non-coding RNA Meg3 deficiency impairs glucose homeostasis and insulin signaling by inducing cellular senescence of hepatic endothelium in obesity. | 2021 | Details |
| A42778 | 33500723 | Theranostics | Activation of N-methyl-D-aspartate receptor regulates insulin sensitivity and lipid metabolism. | 2021 | Details |
| A42789 | 33471689 | Endocr Pract | Role of Androgen in Liver Fat Content in Women: Metabolically Advantageous or Disadvantageous? | 2020 | Details |
| A42802 | 33441256 | Clin Res Hepatol Gastroenterol | Association between gut permeability and insulin resistance: Any role for zonulin in patients with non-alcoholic fatty liver disease? | 2021 | Details |
| A42813 | 33378945 | Biomed Pharmacother | A novel quantitative assay for analysis of GLUT4 translocation using high content screening. | 2020 | Details |
| A42819 | 33353459 | Thyroid | Increased Hepatic Fat Content in Patients with Resistance to Thyroid Hormone Beta. | 2021 | Details |
| A42824 | 33346689 | Physiol Genomics | Cell-free DNA and RNA-measurement and applications in clinical diagnostics with focus on metabolic disorders. | 2020 | Details |
| A42837 | 33337585 | Ultrasound Q | Liver Stiffness Is Increased in Polycystic Ovary Syndrome and Related With Complement C1q/Tumor Necrosis Factor-Related Protein 3 Levels: A Point Shear Wave Elastography Study. | 2020 | Details |
| A42858 | 33277657 | J Clin Endocrinol Metab | Elevated Circulating Glutamate Is Associated With Subclinical Atherosclerosis Independently of Established Risk Markers: A Cross-Sectional Study. | 2021 | Details |
| A42863 | 33259630 | Toxicol Sci | Gestational Cd Exposure in the CD-1 Mouse Induces Sex-Specific Hepatic Insulin Insensitivity, Obesity, and Metabolic Syndrome in Adult Female Offspring. | 2020 | Details |
| A42896 | 33164861 | Metabolism | Commentary: Nonalcoholic or metabolic dysfunction-associated fatty liver disease? The epidemic of the 21st century in search of the most appropriate name. | 2020 | Details |
| A42908 | 33142057 | J Med Chem | A Novel N-Substituted Valine Derivative with Unique Peroxisome Proliferator-Activated Receptor γ Binding Properties and Biological Activities. | 2020 | Details |
| A42912 | 33123088 | Front Endocrinol (Lausanne) | The Impact of Adipose Tissue-Derived miRNAs in Metabolic Syndrome, Obesity, and Cancer. | 2020 | Details |
| A42913 | 33117357 | Front Immunol | Role of the Nuclear Receptor Corepressor 1 (NCOR1) in Atherosclerosis and Associated Immunometabolic Diseases. | 2020 | Details |
| A42929 | 33053354 | Cell Rep | Prostaglandin E2-EP4 Axis Promotes Lipolysis and Fibrosis in Adipose Tissue Leading to Ectopic Fat Deposition and Insulin Resistance. | 2020 | Details |
| A42968 | 32930521 | Liver Int | MAFLD vs NAFLD: Let the contest begin! | 2020 | Details |
| A42969 | 32930093 | Elife | SWELL1 regulates skeletal muscle cell size, intracellular signaling, adiposity and glucose metabolism. | 2020 | Details |
| A42975 | 32914727 | Endocr Metab Immune Disord Drug Targets | Berberine as a Potential Multi-Target Agent for Metabolic Diseases: A Review of Investigations for Berberine. | 2021 | Details |
| A42978 | 32899741 | Life (Basel) | Fatty Liver, and Not Visceral Fat, Is More Associated with Liver Fibrosis and Diabetes in Non-Obese Japanese Individuals: A Cross-Sectional Study. | 2020 | Details |
| A42990 | 32882164 | Cell Metab | A Membrane-Bound Diacylglycerol Species Induces PKCϵ-Mediated Hepatic Insulin Resistance. | 2020 | Details |
| A42994 | 32869840 | Clin Infect Dis | Fatty Liver Disease in a Prospective North American Cohort of Adults With Human Immunodeficiency Virus and Hepatitis B Virus Coinfection. | 2021 | Details |
| A43021 | 32795106 | Metab Syndr Relat Disord | Metabolic Syndrome in Children and Adolescents: Is There a Universally Accepted Definition? Does it Matter? | 2020 | Details |
| A43032 | 32758101 | J Am Coll Nutr | Interplay Between Insulin Resistance and Body Fat Mass in Evolution of Perturbations Linked to the Metabolic Syndrome in Non-Diabetics: Emphasis on Inflammatory Factors. | 2020 | Details |
| A43035 | 32751062 | Int J Mol Sci | Consumption of Wild Rice (Zizania latifolia) Prevents Metabolic Associated Fatty Liver Disease through the Modulation of the Gut Microbiota in Mice Model. | 2020 | Details |
| A43044 | 32707055 | Metabolism | Making progress in nonalcoholic fatty liver disease (NAFLD) as we are transitioning from the era of NAFLD to dys-metabolism associated fatty liver disease (DAFLD). | 2020 | Details |
| A43045 | 32702498 | Ann Hepatol | Enriched MACK-3 following CHAI and MACK-3 for the noninvasive diagnosis of nonalcoholic steatohepatitis. | 2020 | Details |
| A43047 | 32697967 | EBioMedicine | Thrombospondin1 as a potential therapeutic target for human nonalcoholic fatty liver disease. | 2020 | Details |
| A43053 | 32693115 | J Ethnopharmacol | A review of the processed Polygonum multiflorum (Thunb.) for hepatoprotection: Clinical use, pharmacology and toxicology. | 2020 | Details |
| A43063 | 32652034 | J Nutr | A Low ω-6 to ω-3 PUFA Ratio (n-6:n-3 PUFA) Diet to Treat Fatty Liver Disease in Obese Youth. | 2020 | Details |
| A43087 | 32598598 | Ter Arkh | [Diabetes mellitus and chronic liver diseases. Literature review (part 2): treatment features]. | 2019 | Details |
| A43094 | 32586106 | Antioxid Redox Signal | Phospholipase D as a Potential Modulator of Metabolic Syndrome: Impact of Functional Foods. | 2020 | Details |
| A43095 | 32585124 | Appl Physiol Nutr Metab | Lipid droplets are both highly oxidized and Plin2-covered in hepatocytes of diet-induced obese mice. | 2020 | Details |
| A43098 | 32571750 | Clin Res Hepatol Gastroenterol | Cytochrome P450 2E1 should not be neglected for acetaminophen-induced liver injury in metabolic diseases with altered insulin levels or glucose homeostasis. | 2020 | Details |
| A43108 | 32549999 | Clin Hypertens | Uric acid and cardiometabolic diseases. | 2020 | Details |
| A43131 | 32482717 | J Lipid Res | Lecithin:cholesterol acyltransferase: symposium on 50 years of biomedical research from its discovery to latest findings. | 2020 | Details |
| A43132 | 32479251 | Endocr Metab Immune Disord Drug Targets | Positive Correlation between Circulating Fetuin-A and Severity of Coronary Artery Disease in Men. | 2021 | Details |
| A43160 | 32403898 | Clin Exp Pediatr | Early menarche and its consequence in Korean female: reducing fructose intake could be one solution. | 2020 | Details |
| A43173 | 32374328 | Biomater Sci | A versatile ultrafine and super-absorptive H+-modified montmorillonite: application for metabolic syndrome intervention and gastric mucosal protection. | 2020 | Details |
| A43192 | 32338040 | Antioxid Redox Signal | Glycomacropeptide: A Bioactive Milk Derivative to Alleviate Metabolic Syndrome Outcomes. | 2020 | Details |
| A43246 | 32184272 | Diabetes | Branched-Chain Amino Acids Exacerbate Obesity-Related Hepatic Glucose and Lipid Metabolic Disorders via Attenuating Akt2 Signaling. | 2020 | Details |
| A43248 | 32181687 | DNA Cell Biol | DES1: A Key Driver of Lipotoxicity in Metabolic Disease. | 2020 | Details |
| A43262 | 32122723 | J Hepatol | β-arrestin: Dr Jekyll and Mr Hyde in NASH and fibrosis. | 2020 | Details |
| A43268 | 32109931 | Eur J Gastroenterol Hepatol | Homeostasis model assessment of insulin resistance and lobular inflammation in nondiabetic patients with nonalcoholic fatty liver disease: methodological considerations. | 2020 | Details |
| A43313 | 32006524 | Transl Res | Role of placental fibrinogen-like protein 1 in gestational diabetes. | 2020 | Details |
| A43330 | 31979841 | J Assoc Physicians India | Insulin Resistance, Dyslipidaemia and Glycemic Abnormalities in Nondiabetic NAFLD (Non Alcoholic Fatty Liver Disease). | 2020 | Details |
| A43331 | 31979839 | J Assoc Physicians India | Study of Correlation between Carotid Intimalthickness and Insulin Resistance in Patients with NAFLD. | 2020 | Details |
| A43348 | 31930974 | Metabolism | Obeticholic acid for the treatment of nonalcoholic steatohepatitis: Expectations and concerns. | 2020 | Details |
| A43359 | 31910158 | Endocr Connect | Lipid accumulation product independently correlate with hepatic steatosis quantified by controlled attenuation parameter in women with polycystic ovary syndrome. | 2020 | Details |
| A43363 | 31903735 | Obesity (Silver Spring) | Adipose Tissue Macrophage Phenotypes and Characteristics: The Key to Insulin Resistance in Obesity and Metabolic Disorders. | 2020 | Details |
| A43369 | 31899812 | Hepatology | Ceramides: A Cause of Insulin Resistance in Nonalcoholic Fatty Liver Disease in Both Murine Models and Humans. | 2020 | Details |
| A43380 | 31871510 | Curr Ther Res Clin Exp | Hepatoprotective Effects of a Ruthenium(II) Schiff Base Complex in Rats with Diet-Induced Prediabetes. | 2019 | Details |
| A43395 | 31845444 | Phytother Res | Bitter melon fruit extract has a hypoglycemic effect and reduces hepatic lipid accumulation in ob/ob mice. | 2019 | Details |
| A43399 | 31834843 | J Med Food | Natural Products: New Hope for Nonalcoholic Steatohepatitis? | 2019 | Details |
| A43425 | 31754898 | Curr Diab Rep | Hyperglycemia During Pregnancy and Long-Term Offspring Outcomes. | 2019 | Details |
| A43448 | 31693811 | N Engl J Med | Nonalcoholic Fatty Liver Disease, Insulin Resistance, and Ceramides. | 2019 | Details |
| A43450 | 31680281 | Hepatology | Liver Fat and Cardiometabolic Risk Factors Among School-Age Children. | 2020 | Details |
| A43460 | 31663469 | Curr Med Chem | Effects of Pterostilbene on Diabetes, Liver Steatosis and Serum Lipids. | 2021 | Details |
| A43468 | 31649547 | Front Pharmacol | Mitophagy in Hepatic Insulin Resistance: Therapeutic Potential and Concerns. | 2019 | Details |
| A43486 | 31592705 | Metab Syndr Relat Disord | Triglycerides as a Metabolic Target in Afrocaribbean Infertile Women with Polycystic Ovary Syndrome. | 2019 | Details |
| A43492 | 31587376 | Biofactors | Discovery of a role of the novel hepatokine, hepassocin, in obesity. | 2019 | Details |
| A43496 | 31584530 | J Cardiovasc Pharmacol | NLRP3 Inflammasome: A Novel Player in Metabolically Induced Inflammation-Potential Influence on the Myocardium. | 2019 | Details |
| A43497 | 31582899 | Mediators Inflamm | Pattern Recognition Receptor-Mediated Chronic Inflammation in the Development and Progression of Obesity-Related Metabolic Diseases. | 2019 | Details |
| A43503 | 31573550 | J Clin Invest | The gut microbiome and metabolic syndrome. | 2019 | Details |
| A43504 | 31570275 | J Hepatol | Endoscopic bariatric and metabolic therapies for non-alcoholic fatty liver disease. | 2019 | Details |
| A43602 | 31311004 | J Endocrinol | Assessment of mouse liver [1-13C]pyruvate metabolism by dynamic hyperpolarized MRS. | 2019 | Details |
| A43604 | 31301829 | J Dairy Sci | Invited review: Sphingolipid biology in the dairy cow: The emerging role of ceramide. | 2019 | Details |
| A43607 | 31300671 | Sci Rep | Insulin resistance and metabonomics analysis of fatty liver haemorrhagic syndrome in laying hens induced by a high-energy low-protein diet. | 2019 | Details |
| A43627 | 31258478 | Front Pharmacol | Therapeutic Mechanisms of Herbal Medicines Against Insulin Resistance: A Review. | 2019 | Details |
| A43639 | 31237448 | Am J Physiol Endocrinol Metab | Obeticholic acid ameliorates dyslipidemia but not glucose tolerance in mouse model of gestational diabetes. | 2019 | Details |
| A43643 | 31227258 | J Hepatol | Hepatic fat: Pathogenic trigger or passenger? | 2019 | Details |